Press release
Cardiac Biomarkers Market Expected to Reach 17.55 Billion by 2028, Driven by Rising Cardiovascular Disease Burden
Cardiac Biomarkers Market
Market Overview
Cardiac biomarkers are substances found in the blood that indicate the health and function of the heart. They play a crucial role in diagnosing and monitoring various cardiac conditions, including heart attack, heart failure, and arrhythmias. Some of the most commonly used cardiac biomarkers include troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), and high-sensitivity C-reactive protein (hs-CRP).
Download Free Exclusive Sample PDF@ https://www.reportsanddata.com/download-free-sample/1423
Key Trends
Technological advancements: The development of novel diagnostic assays with higher sensitivity and specificity is driving market growth. For instance, high-sensitivity troponin assays can detect heart damage earlier and more accurately than traditional tests .
Growing geriatric population: The increasing prevalence of CVDs in the aging population is a major growth factor. As per the World Health Organization, CVDs are the leading cause of death globally, claiming an estimated 18 million lives each year .
Rising healthcare awareness: Growing public awareness about the importance of early diagnosis and treatment of heart disease is fueling market expansion.
Drivers and Restraints
Drivers:
Increasing burden of CVDs
Technological advancements in cardiac diagnostics
Rising healthcare expenditure
Growing focus on personalized medicine
Restraints:
High cost of advanced biomarker tests
Limited reimbursement policies
Stringent regulatory requirements
Growth Opportunities
Development of multiplex assays for simultaneous detection of multiple cardiac biomarkers
Expansion into emerging markets
Growing adoption of point-of-care testing devices
Key Market Insights
Companies considered and profiled in this market study:
The Global Cardiac Biomarkers Market study postulates constructive intuition globally which includes the companies who are the key players in Global Cardiac Biomarkers Market, such as
Abbott Laboratories, Beckman Coulter, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Acquire the complete research report on the GlobalMarket@ https://www.reportsanddata.com/report-detail/cardiac-biomarkers-market
Segments covered in the report:
For the purpose of the study, this report segments the Global Cardiac Biomarkers Market on the basis of product type, location of testing type, application, end user and the regional outlook at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2028.
Product Type (Revenue, USD Million; 2020-2028)
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia Modified Albumin (IMA)
Myoglobin
Troponins (T and I)
Myocardial muscle Creatine Kinase (CK-MB)
Others
Location of Testing (Revenue, USD Million; 2020-2028)
Laboratory Testing
Point of Care Testing
Application (Revenue, USD Million; 2020-2028)
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
End User (Revenue, USD Million; 2020-2028)
Diagnostic Laboratories
Hospitals and Clinics
Regional Outlook: (Revenue, USD Million; 2020-2028)
North America
U.S.
Canada
Europe
Germany
UK
Spain
France
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Middle East and Africa (MEA)
Request For Customization Report@ https://www.reportsanddata.com/request-customization-form/1423
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarkers Market Expected to Reach 17.55 Billion by 2028, Driven by Rising Cardiovascular Disease Burden here
News-ID: 3558653 • Views: …
More Releases from Reports and Data
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility.
Market Drivers
Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant…
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies.
Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490
Passenger vehicles remain the largest segment of…
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations.
Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489
Electric and…
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies.
Electric vehicles (EVs) are the main driver behind this surge, as…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
